| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
November 2009 - 92 products |
|
| | IP | CI | A | Targin 5 mg/2.5 mg | 30 Tablet(s) | 17.80 | 35.25 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 5 mg/2.5 mg | 60 Tablet(s) | 31.32 | 49.55 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 10 mg/5 mg | 30 Tablet(s) | 27.18 | 45.15 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 10 mg/5 mg | 60 Tablet(s) | 47.79 | 66.95 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 20 mg/10 mg | 30 Tablet(s) | 45.83 | 64.90 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 20 mg/10 mg | 60 Tablet(s) | 87.62 | 109.10 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 40 mg/20 mg | 30 Tablet(s) | 84.87 | 106.15 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
| | IP | CI | A | Targin 40 mg/20 mg | 60 Tablet(s) | 163.93 | 189.80 | 20 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/500 | 60 Tablet(s) | 22.27 | 40.50 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/500 | 180 Tablet(s) | 66.83 | 88.70 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/850 | 60 Tablet(s) | 22.27 | 40.50 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/850 | 180 Tablet(s) | 66.83 | 88.70 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/1000 | 60 Tablet(s) | 22.27 | 40.50 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Galvumet 50/1000 | 180 Tablet(s) | 66.83 | 88.70 | 10 % | | Coated tablets: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Afinitor 5 mg | 30 Tablet(s) | 1049.49 | 1144.90 | 10 % | | Tablets: Everolimusum 5 mg | Novartis Pharma Schweiz AG | A / SL / SO | FB | | G |  |
L | | IP | CI | | Afinitor 10 mg | 30 Tablet(s) | 1510.79 | 1640.90 | 10 % | | Tablets: Everolimusum 10 mg | Novartis Pharma Schweiz AG | A / SL / SO | FB | | G |  |
L | | IP | | | Amiodarone Labatec | 10 ampoule(s) | 21.16 | 39.45 | 10 % | | Injection solution: Amiodaroni Hydrochloridum 50 mg/ml | Labatec Pharma SA | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 5 oro | 28 Tablet(s) | 32.68 | 51.95 | 10 % | | Melting tablets: Olanzapinum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 5 oro | 98 Tablet(s) | 91.13 | 115.60 | 10 % | | Melting tablets: Olanzapinum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 7.5 oro | 28 Tablet(s) | 39.80 | 59.85 | 10 % | | Melting tablets: Olanzapinum 7.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 10 oro | 28 Tablet(s) | 58.93 | 80.40 | 10 % | | Melting tablets: Olanzapinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 10 oro | 98 Tablet(s) | 164.34 | 195.05 | 10 % | | Melting tablets: Olanzapinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 15 oro | 28 Tablet(s) | 85.84 | 109.60 | 10 % | | Melting tablets: Olanzapinum 15 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 15 oro | 98 Tablet(s) | 239.36 | 276.60 | 10 % | | Melting tablets: Olanzapinum 15 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 20 oro | 28 Tablet(s) | 114.46 | 140.70 | 10 % | | Melting tablets: Olanzapinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 20 oro | 98 Tablet(s) | 319.18 | 363.55 | 10 % | | Melting tablets: Olanzapinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Valaciclovir Therica 500 mg - T | 10 | 11.32 | 28.70 | 10 % | | Coated tablets: Valaciclovirum 500 mg | Bailleul (Suisse) SA | A / SL / SG | FB | | G |  |
| | IP | CI | | Valaciclovir Therica 500 mg - T | 30 | 33.26 | 52.55 | 10 % | | Coated tablets: Valaciclovirum 500 mg | Bailleul (Suisse) SA | A / SL / SG | FB | | G |  |
| | IP | CI | | Valaciclovir Therica 500 mg - T | 42 | 44.93 | 65.30 | 10 % | | Coated tablets: Valaciclovirum 500 mg | Bailleul (Suisse) SA | A / SL / SG | FB | | G |  |
| | IP | CI | | Clindamycin Sandoz 150 | 16 Capsule(s) | 7.71 | 17.60 | 10 % | | Capsules: Clindamycinum 150 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Clindamycin Sandoz 300 | 16 Capsule(s) | 11.76 | 29.20 | 10 % | | Capsules: Clindamycinum 300 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 2.5 | 28 Tablet(s) | 19.47 | 37.60 | 10 % | | Tablets: Olanzapinum 2.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 2.5 | 98 Tablet(s) | 55.55 | 76.85 | 10 % | | Tablets: Olanzapinum 2.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 5 | 28 Tablet(s) | 32.70 | 51.95 | 10 % | | Tablets: Olanzapinum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 5 | 98 Tablet(s) | 91.26 | 115.75 | 10 % | | Tablets: Olanzapinum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 7.5 | 28 Tablet(s) | 44.39 | 64.55 | 10 % | | Tablets: Olanzapinum 7.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 10 | 28 Tablet(s) | 56.28 | 77.65 | 10 % | | Tablets: Olanzapinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 10 | 98 Tablet(s) | 160.53 | 191.15 | 10 % | | Tablets: Olanzapinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 15 | 28 Tablet(s) | 81.95 | 105.60 | 10 % | | Tablets: Olanzapinum 15 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 15 | 98 Tablet(s) | 233.07 | 270.15 | 10 % | | Tablets: Olanzapinum 15 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 20 | 28 Tablet(s) | 109.00 | 135.10 | 10 % | | Tablets: Olanzapinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Avalox | 250 ml | 45.55 | 65.95 | 10 % | | Infusion solution: Moxifloxacinum 400 mg | Bayer (Schweiz) AG | A / SL | FB | | G |  |
| | IP | | | Diclofenac-Mepha 75 | 5 ampoule(s) | 2.90 | 12.40 | 10 % | | Injection solution: 2 Active Agents | Mepha Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Diclofenac-Mepha 75 | 25 ampoule(s) | 14.30 | 31.95 | 10 % | | Injection solution: 2 Active Agents | Mepha Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Diclofenac-Mepha 75 | 50 ampoule(s) | 27.80 | 46.65 | 10 % | | Injection solution: 2 Active Agents | Mepha Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Targin 60 mg/30 mg | 30 Tablet(s) | 115.81 | 142.35 | 10 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Targin 60 mg/30 mg | 60 | 223.77 | 259.80 | 10 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Targin 80 mg/40 mg | 30 Tablet(s) | 139.20 | 167.80 | 10 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Targin 80 mg/40 mg | 60 | 268.85 | 308.80 | 10 % | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | | | Flumazenil Sintetica 0,5 mg/5 ml | 10 1 ampoule(s) à 5 ml | PR | PR | k.A. | | Injection solution: Flumazenilum | Sintetica SA | B | FB | | G |  |
| | IP | | | Flumazenil Sintetica 1 mg/10 ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Flumazenilum 1mg / 10ml | Sintetica SA | B | FB | | G |  |
| | IP | | | Magnesiumsulfat Bichsel 10% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 100 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | Magnesiumsulfat Bichsel 20% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 200 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | Magnesiumsulfat Bichsel 50% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 500 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 7.5 oro | 98 Tablet(s) | PR | PR | k.A. | | Melting tablets: Olanzapinum 7.5 mg | Mepha Pharma AG | B | FB | | G |  |
| | IP | CI | | Circadin | 21 Tablet(s) | PR | PR | k.A. | | Delayed release tablets: Melatoninum 2 mg | NEURIM PHARMACEUTICALS AG | B | FB | | G |  |
| | IP | CI | | Targin 5 mg/2.5 mg | 5 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 5 mg/2.5 mg | 10 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 5 mg/2.5 mg | 14 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 5 mg/2.5 mg | 20 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 5 mg/2.5 mg | 28 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 10 mg/5 mg | 5 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 10 mg/5 mg | 10 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 10 mg/5 mg | 14 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 10 mg/5 mg | 20 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 10 mg/5 mg | 28 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 20 mg/10 mg | 5 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 20 mg/10 mg | 10 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 20 mg/10 mg | 14 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 20 mg/10 mg | 20 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 20 mg/10 mg | 28 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 40 mg/20 mg | 5 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 40 mg/20 mg | 10 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 40 mg/20 mg | 14 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 40 mg/20 mg | 20 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Targin 40 mg/20 mg | 28 | PR | PR | k.A. | | Delayed release tablets: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | CI | | Valaciclovir Therica 250 mg | 60 | PR | PR | k.A. | | Coated tablets: Valaciclovirum 250 mg | Bailleul (Suisse) SA | A | FB | | G |  |
| | IP | CI | | Valaciclovir Therica 500 mg - T | 90 | 92.75 | 117.05 | k.A. | | Coated tablets: Valaciclovirum 500 mg | Bailleul (Suisse) SA | A | FB | | G |  |
| | | CI | Ph | Vigor Eleutherococcus | 50 Capsule(s) | PR | 24.00 | k.A. | | Capsules: Eleutherococci Radicis Extractum Ethanolicum Siccum 19.5-16.5 mg | Herbamed AG | D / LPPV | FB | | G |  |
| | | CI | Ph | Vigor Eleutherococcus | 100 Capsule(s) | PR | PR | k.A. | | Capsules: Eleutherococci Radicis Extractum Ethanolicum Siccum 19.5-16.5 mg | Herbamed AG | D | FB | | G |  |
| | IP | CI | | Afinitor 2.5 mg | 30 Tablet(s) | PR | PR | k.A. | | Tablets: Everolimusum 2.5 mg | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IP | CI | | Lysodren | 100 Tablet(s) | PR | PR | k.A. | | Tablets: Mitotanum 500 mg | EffRx Pharmaceuticals SA | A | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 7.5 | 98 Tablet(s) | PR | PR | k.A. | | Tablets: Olanzapinum 7.5 mg | Mepha Pharma AG | B | FB | | G |  |
| | IP | CI | | Olanzapin-Mepha 20 | 98 Tablet(s) | PR | PR | k.A. | | Tablets: Olanzapinum 20 mg | Mepha Pharma AG | B | FB | | G |  |
| | IP | | | Adrenalin Sintetica 1,0 mg/ml | 10 1 ampoule(s) à 1 ml | PR | PR | k.A. | | soluzione iniettabile / concentrato per soluzione iniettabile/per infusione: Adrenalinum 1 mg/ml | Sintetica SA | B | FB | | G |  |
| | IP | | | Pantoprazol Sandoz i.v. | | PR | PR | k.A. | | Lyophilisate: Pantoprazolum 40 mg | Sandoz Pharmaceuticals AG | | FB | | G |  |
| | IP | CI | | Cefurox Actavis 125 mg | 14 Tablet(s) | 6.03 | 15.10 | k.A. | | Coated tablets: Cefuroximum 125 mg | Actavis Switzerland AG | A | FB | | G |  |
| | IP | CI | | Cefurox Actavis 125 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 125 mg | Actavis Switzerland AG | A | FB | | G |  |
| | IP | CI | | Cefurox Actavis 250 mg | 14 Tablet(s) | 10.99 | 20.80 | k.A. | | Coated tablets: Cefuroximum 250 mg | Actavis Switzerland AG | A | FB | | G |  |
| | IP | CI | | Cefurox Actavis 250 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 250 mg | Actavis Switzerland AG | A | FB | | G |  |
| | IP | CI | | Cefurox Actavis 500 mg | 14 Tablet(s) | 17.69 | 36.70 | k.A. | | Coated tablets: Cefuroximum 500 mg | Actavis Switzerland AG | A | FB | | G |  |
| | IP | CI | | Cefurox Actavis 500 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 500 mg | Actavis Switzerland AG | A | FB | | G |  |